Phillip M. Rappold, Ph.D.

Affiliations: 
2013 School of Medicine and Dentistry University of Rochester, Rochester, NY 
Area:
Neuroscience Biology, General Biology, Pathology
Google:
"Phillip Rappold"
Mean distance: 53433
 

Parents

Sign in to add mentor
Kim Tieu grad student 2013 Rochester
 (Pathogenic Mechanisms and Novel Therapeutic Strategies in Parkinson Disease.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rappold PM, Cui M, Grima JC, et al. (2014) Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo. Nature Communications. 5: 5244
Rappold PM, Cui M, Chesser AS, et al. (2011) Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3. Proceedings of the National Academy of Sciences of the United States of America. 108: 20766-71
Lim S, Chesser AS, Grima JC, et al. (2011) D-β-hydroxybutyrate is protective in mouse models of Huntington's disease. Plos One. 6: e24620
Rappold PM, Tieu K. (2010) Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 413-23
Cui M, Aras R, Christian WV, et al. (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America. 106: 8043-8
See more...